[Table 1].
Impact of pro-longevity interventions on the aging microbiome.
Pro-longevity intervention | Organism | Site | Effect on microbiome | Microbiome profiling | Reference |
---|---|---|---|---|---|
Calorie restriction | M. musculus | Gut | - Gut microbiota required for CR-induced weight loss - Significant increases in Lactobacillus, Bifidobacterium - Decreased B/F ratio |
V4 16S V3-V4 16S |
[83, 84, 219] |
R. norvegicus | Gut | - Increase of Lactobacillus - Increased B/F ratio - Changes in microbial SCFA production (Increased propionogenesis, decreased butyrogenesis and acetogenesis) |
V4 16S Full length 16S Metaproteomics |
[220, 221] | |
Dwarfism (Ames) |
M. musculus | Gut | - Increased B/F ratio |
V4 16S |
[219] |
Metformin | C. elegans | Gut (food source) |
- Changes the E. coli metabolism of folate and methionine - E. coli required for longevity extension |
N/A | [222] |
H. sapiens | Gut | - Increased E. coli abundance - Increased production of SCFAs |
V4 16S Metagenomics |
[223–225] | |
M. musculus | Gut | - Increased B/F ratio- Increased abundance of Lactobacillus | V4 16S | [226] | |
Rapamycin | M. musculus | Oral | - Rejuvenation of the oral microbiome | V4 16S | [13] |
M. musculus | Gut | - Increased prevalence of segmented filamentous bacteria - Remodeling of specific OTUs - No change in B/F ratio - Renders microbiome more similar to that of HFD-treated mice |
V4 16S Full length 16S (Sequencing and PhyloChip) |
[227–229] | |
Resveratrol | M. musculus | Gut | - No change in B/F ratio - Reverses HFD-induced changes in bacterial abundances |
Full length 16S | [229] |
Mediterranean diet | H. sapiens | Gut | - Increased taxa associated to lower frailty in aged humans - Predicted increase in microbial SCFA production |
V3-V4 16S | [230] |
Acarbose | M. musculus | Gut | - Increased abundance in Muribaculaceae - Increase in microbial SCFAs, including propionate |
V4 16S | [231] |
HFD: High-fat diet
B/F: Bacteroidetes/ Firmicutes